These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18452635)

  • 1. Evaluation of irradiated salivary gland function in patients with head and neck tumours treated with radiotherapy.
    Baharudin A; Khairuddin A; Nizam A; Samsuddin AR
    J Laryngol Otol; 2009 Jan; 123(1):108-13. PubMed ID: 18452635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
    Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
    Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
    Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative change in saliva secretion in relation to the exposed area of the salivary glands after radiotherapy of head and neck region.
    Karlsson G
    Swed Dent J; 1987; 11(5):189-94. PubMed ID: 3481134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy.
    Jen YM; Lin YC; Wang YB; Wu DM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):322-7. PubMed ID: 16504865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer.
    Tenhunen M; Collan J; Kouri M; Kangasmäki A; Heikkonen J; Kairemo K; Mäkitie A; Joensuu H; Saarilahti K
    Radiother Oncol; 2008 May; 87(2):260-7. PubMed ID: 18329118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sparing of contralateral major salivary glands has a significant effect on oral health in patients treated with radical radiotherapy of head and neck tumors.
    Beer KT; Zehnder D; Lussi A; Greiner RH
    Strahlenther Onkol; 2002 Dec; 178(12):722-6. PubMed ID: 12491061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
    Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
    Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.
    Saarilahti K; Kouri M; Collan J; Hämäläinen T; Atula T; Joensuu H; Tenhunen M
    Radiother Oncol; 2005 Mar; 74(3):251-8. PubMed ID: 15763305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
    Chambers MS; Tomsett KL; Artopoulou II; Garden AS; El-Naggar AK; Martin JW; Keene HJ
    J Prosthet Dent; 2008 Aug; 100(2):142-6. PubMed ID: 18672129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term parotid gland function after radiotherapy.
    Braam PM; Roesink JM; Moerland MA; Raaijmakers CP; Schipper M; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):659-64. PubMed ID: 15936542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function.
    Veerasarn V; Phromratanapongse P; Suntornpong N; Lorvidhaya V; Sukthomya V; Chitapanarux I; Tesavibul C; Swangsilpa T; Khorprasert C; Shotelersuk K; Kongthanarat Y; Panichevaluk A; Chiewvit S; Pusuwan P; Aekmahachai M; Ratchadara S; Sirilipoche S; Saengsuda Y
    J Med Assoc Thai; 2006 Dec; 89(12):2056-67. PubMed ID: 17214057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer patients.
    Kakoei S; Haghdoost AA; Rad M; Mohammadalizadeh S; Pourdamghan N; Nakhaei M; Bahador M
    Arch Iran Med; 2012 Apr; 15(4):214-8. PubMed ID: 22424038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative radiation dose-response relationships for normal tissues in man. II. Response of the salivary glands during radiotherapy.
    Mossman KL
    Radiat Res; 1983 Aug; 95(2):392-8. PubMed ID: 6611856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.